Coinsilium Group Limited #COIN – Holding in Company and Total Voting Rights December 1, 2021 – Posted in: Blog, Coinsilium (COIN)

Coinsilium Group Limited: Holding in Company Total Voting Rights London, UK, 1 December 2021 – Coinsilium Group Limited (AQSE: COIN) (OTCQB: CINGF), the Blockchain, and Open Finance venture builder, hereby announces that it was informed on 1 December 2021 by Great North Star International Inc that it has acquired 4,580,000 ordinary shares, taking its holding to 10,830,000 ordinary shares of nil par value in the Company, representing 6.19% of the 174,748,235 ordinary shares…

Union Jack Oil #UJO – Total Voting Rights March 31, 2021 – Posted in: Union Jack Oil (UJO)

31st March, 2021 Union Jack Oil plc (“Union Jack” or the “Company”) Total Voting Rights Union Jack Oil plc (AIM: UJO), a UK focused onshore hydrocarbon production, development and exploration company, announces that in accordance with the Financial Conduct Authority’s Disclosure and Transparency Rules (“DTRs”), the total issued share capital of the Company with voting rights is 99,079,532 ordinary shares. There are no shares currently held in treasury. The total number of voting rights in the Company is therefore 99,079,532 and this figure…

Tiziana Life Sciences October 26, 2020 – Posted in: Tiziana Life Sciences (TILS)

26th October, 2020 Tiziana Life Sciences Plc (“Tiziana” or the “Company”) Exercise of options, Issue of Equity PDMR Dealing and Total Voting Rights Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, today announces that it has allotted and issued 329,225 ordinary shares of 3 pence each (“New Ordinary Shares”) credited as fully paid at a price of…

(No title) October 21, 2020 – Posted in: Tiziana Life Sciences (TILS)

21st October, 2020 Tiziana Life Sciences Plc (“Tiziana” or the “Company”) Exercise of options, Issue of Equity PDMR Dealing and Total Voting Rights Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, today announces that it has allotted and issued total of 1,750,000 ordinary shares of 3 pence each (“New Ordinary Shares”) credited as fully paid; (i) in…

Tiziana Life Sciences – Issue of Equity & Total Voting Rights September 21, 2020 – Posted in: Tiziana Life Sciences (TILS)

21st September, 2020 Tiziana Life Sciences Plc (“Tiziana” or the “Company”) Issue of Equity and Total Voting Rights Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, today announces that it has allotted and issued 281,250 ordinary shares of 3 pence each (“New Ordinary Shares”) credited as fully paid at a price of 128 pence per share in…

Tiziana Life Sciences – Exercise of Warrants & Issue of Equity & Total Voting Rights July 24, 2020 – Posted in: Uncategorized

24th July, 2020 Tiziana Life Sciences plc (“Tiziana” or the “Company”) Exercise of Warrants and Issue of Equity and Total Voting Rights London, New York, 24 July 2020 – Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, today announces that it has allotted and issued 88,580 ordinary shares of 3 pence each (“New Ordinary Shares”) credited as fully paid in respect of…

Tiziana Life Sciences – Totoal Voting Rights & StemPrintER Demerger Update July 1, 2020 – Posted in: Tiziana Life Sciences (TILS)

Wednesday 1st July, 2020 Tiziana Life Sciences plc (“Tiziana” or the “Company”) Total Voting Rights and StemPrintER Demerger Update London, New York, 1 July 2020 – Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (the “Company” or “Tiziana”), a US and UK biotechnology company that focuses on the discovery and development of novel molecules to treat human disease in oncology and immunology, today announces that plans to effect the demerger of StemPrintER from the Group are continuing to be progressed and…

Tiziana Life Sciences plc – Exercise of Warrants and Issue of Equity and Total Voting Rights June 22, 2020 – Posted in: Tiziana Life Sciences (TILS)

Monday 22nd June, 2020 Tiziana Life Sciences plc (“Tiziana” or the “Company”) Exercise of Warrants and Issue of Equity and Total Voting Rights London, New York, 22 June 2020 – Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (the “Company” or “Tiziana”), a US and UK biotechnology company that focuses on the discovery and development of novel molecules to treat human disease in oncology and immunology, today announces that it has allotted and issued 1,800,000 ordinary shares of 3 pence each (“New Ordinary Shares”)…

Tiziana Life Sciences Plc – Exercise of Warrants and Issue of Equity and Total Voting Rights June 3, 2020 – Posted in: Tiziana Life Sciences (TILS)

Tiziana Life Sciences plc (“Tiziana” or the “Company”) Correction – Exercise of Warrants and Issue of Equity and Total Voting Rights The announcement (RNS Number: 6069O) released on 2 June 2020 at 07:00 am stated that 1,498,685 new ordinary shares will be issued yielding £710,843 in cash proceeds, the announcement should have stated the number of shares to be issued is 1,234,399, yielding £578,700 cash proceeds. All other details in the announcement remain unchanged. The amended announcement is set out below:…